Form 4: Celularity Director Parks Acquires Shares via RSU Vesting

Celularity Director Diane L. Parks reported the acquisition of 67,416 Class A Common Stock shares through vested Restricted Stock Units.

Summary

• Diane L. Parks, a Director of Celularity Inc. (CELU), acquired 67,416 shares of Class A Common Stock.
• The transaction occurred on December 19, 2025, and represents the vesting of Restricted Stock Units (RSUs).
• These RSUs were granted under the Celularity Inc. 2021 Equity Incentive Plan.
• The RSUs vested and became exercisable on December 19, 2025, with a transaction price of $0.00 per share.
• Following this acquisition, Diane L. Parks directly beneficially owns a total of 365,021 shares of Celularity Inc. Class A Common Stock.

Sentiment

Score: 7

Explanation: The filing indicates a director's beneficial ownership increased due to the vesting of restricted stock units, which is a standard and generally positive event reflecting long-term incentive alignment.

Positives

• Director Diane L. Parks increased her direct beneficial ownership in Celularity Inc. by 67,416 shares, bringing her total to 365,021 shares.
• The vesting of Restricted Stock Units (RSUs) indicates the fulfillment of long-term incentive compensation for a key director, aligning her interests with shareholders.

Future Outlook

NA

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation, specifically the vesting of Restricted Stock Units (RSUs) for a director. Such filings are common across publicly traded companies as part of their long-term incentive plans to align management interests with shareholder value.

Comparison to Industry Standards

• The grant and vesting of Restricted Stock Units (RSUs) as part of director compensation is a common practice across various industries, including biotechnology and pharmaceuticals, aligning director incentives with long-term company performance.

Stakeholder Impact

• Shareholders: Increased director ownership may signal confidence in the company's future and better alignment of management interests with shareholder value.
• Employees: Reinforces the company's equity incentive program as a mechanism for long-term compensation and retention.

Key Dates

Recommendation

This Form 4 details a routine vesting of Restricted Stock Units for a director, which is a pre-scheduled compensation event and does not provide new material information to warrant a change in investment recommendation. It confirms the director's continued equity stake in the company.

Keywords

Celularity, CELU, Form 4, insider transaction, stock acquisition, director, RSU, restricted stock units, equity incentive plan